Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1998 Feb;77(4):676–677. doi: 10.1038/bjc.1998.108

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

D Mavridou, R Gornall, I G Campbell, D M Eccles
PMCID: PMC2149940  PMID: 9484829

Full text

PDF
676

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avigad S., Barel D., Blau O., Malka A., Zoldan M., Mor C., Fogel M., Cohen I. J., Stark B., Goshen Y. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene. 1997 Apr 3;14(13):1541–1545. doi: 10.1038/sj.onc.1200990. [DOI] [PubMed] [Google Scholar]
  2. Campbell I. G., Eccles D. M., Dunn B., Davis M., Leake V. p53 polymorphism in ovarian and breast cancer. Lancet. 1996 Feb 10;347(8998):393–394. doi: 10.1016/s0140-6736(96)90569-3. [DOI] [PubMed] [Google Scholar]
  3. Lancaster J. M., Brownlee H. A., Wiseman R. W., Taylor J. p53 polymorphism in ovarian and bladder cancer. Lancet. 1995 Jul 15;346(8968):182–182. doi: 10.1016/s0140-6736(95)91239-8. [DOI] [PubMed] [Google Scholar]
  4. Peller S., Kopilova Y., Slutzki S., Halevy A., Kvitko K., Rotter V. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA Cell Biol. 1995 Dec;14(12):983–990. doi: 10.1089/dna.1995.14.983. [DOI] [PubMed] [Google Scholar]
  5. Runnebaum I. B., Tong X. W., König R., Zhao H., Körner K., Atkinson E. N., Kreienberg R., Kieback D. G., Hong Z [corrected to Zhao H. ]. p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet. 1995 Apr 15;345(8955):994–994. doi: 10.1016/s0140-6736(95)90745-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES